Extramedullary blast crisis in a patient with Philadelphia chromosome‐positive chronic myelogenous leukemia in complete cytogenetic remission

Susan O'Brien, Richard Witt, Moshe Talpaz, Hagop Kantarjian

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Treatment of Philadelphia (Ph) chromosome‐positive chronic myelogenous leukemia (CML) with recombinant interferon‐alpha (IFN‐A) results in complete disappearance of the Ph chromosome in about 10% to 15% of patients in early chronic phase. This group has a long survival and very low incidence of blast crisis. The first known case is reported of extramedullary blastic transformation in a patient with medullary complete cytogenetic response (0% Ph‐positive metaphases) to IFN‐A. Four episodes of extramedullary blast crisis have occurred in this patient. The first three episodes were lymphoid by morphology and cytochemical stains. Molecular analysis confirmed breakpoint cluster region rearrangement. The most recent transformation was myeloid in nature and involved bone and pulmonary parenchyma. The patient is currently undergoing a second autologous transplantation with stored bone marrow that is Ph negative. The patient has survived more than 18 months since the first episode of blast crisis, and the bone marrow is normal.

Original languageEnglish (US)
Pages (from-to)1946-1949
Number of pages4
JournalCancer
Volume67
Issue number7
DOIs
StatePublished - Apr 1 1991

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Extramedullary blast crisis in a patient with Philadelphia chromosome‐positive chronic myelogenous leukemia in complete cytogenetic remission'. Together they form a unique fingerprint.

Cite this